Skip to main content
. 2016 Sep 2;311(5):H1132–H1138. doi: 10.1152/ajpheart.00081.2016

Fig. 4.

Fig. 4.

Bars indicate the percent of injected 125I-TyrA14-insulin remaining in plasma at 5 min post iv injection in group 1 (left, with and without treatment with S961) and group 3 (right, with and without HFD) animals. ***P < 0.001.